Literature DB >> 2364368

A performance status scale for head and neck cancer patients.

M A List1, C Ritter-Sterr, S B Lansky.   

Abstract

Effective assessment of treatment outcome and the development of successful rehabilitation for head and neck cancer patients demand an evaluation of the relevant parameters of functional status. This paper reports the development and testing of a new Performance Status Scale for Head and Neck Cancer Patients designed to assess the unique areas of dysfunction experienced by this population. The instrument is a simple, practical, clinician-rated assessment tool consisting of three subscales: (1) Understandability of Speech, (2) Normalcy of Diet, and (3) Eating in Public. The scale was administered to a group of 181 head and neck patients and a comparison group of 30 breast cancer patients. Results indicate that the scale is reliable across raters and sensitive to functional differences across a broad spectrum of head and neck cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2364368     DOI: 10.1002/1097-0142(19900801)66:3<564::aid-cncr2820660326>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  113 in total

1.  Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

Authors:  M A List; P Mumby; D Haraf; A Siston; R Mick; E MacCracken; E Vokes
Journal:  Qual Life Res       Date:  1997-04       Impact factor: 4.147

2.  Acupuncture for dysphagia after chemoradiation in head and neck cancer: rationale and design of a randomized, sham-controlled trial.

Authors:  Weidong Lu; Peter M Wayne; Roger B Davis; Julie E Buring; Hailun Li; Laura A Goguen; David S Rosenthal; Roy B Tishler; Marshall R Posner; Robert I Haddad
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

3.  Subtotal laryngectomy: outcomes of 469 patients and proposal of a comprehensive and simplified classification of surgical procedures.

Authors:  G Rizzotto; E Crosetti; M Lucioni; G Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06       Impact factor: 2.503

4.  Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.

Authors:  Rajesh V Lalla; Linda E Choquette; Kathleen F Curley; Robert J Dowsett; Richard S Feinn; Upendra P Hegde; Carol C Pilbeam; Andrew L Salner; Stephen T Sonis; Douglas E Peterson
Journal:  Oral Oncol       Date:  2014-08-21       Impact factor: 5.337

Review 5.  The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review.

Authors:  Thomas M Atkinson; Charissa F Andreotti; Kailey E Roberts; Rebecca M Saracino; Marisol Hernandez; Ethan Basch
Journal:  Support Care Cancer       Date:  2015-08-28       Impact factor: 3.603

6.  Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.

Authors:  Lauren Ottenstein; Hannah Cornett; Jeffrey M Switchenko; Meghana Nathan; Susan Thomas; Amanda I Gillespie; Nancy McColloch; Tiffany Barrett; Matthew B Studer; Meghan Brinkman; Azeem S Kaka; Brian J Boyce; Robert L Ferris; Ashley H Aiken; Mark El-Deiry; Jonathan J Beitler; Mihir R Patel
Journal:  Head Neck       Date:  2021-02-05       Impact factor: 3.147

7.  Development and validation of a cancer-specific swallowing assessment tool: MASA-C.

Authors:  Giselle D Carnaby; Michael A Crary
Journal:  Support Care Cancer       Date:  2013-10-19       Impact factor: 3.603

8.  Psychological distress in patients and caregivers over the course of radiotherapy for head and neck cancer.

Authors:  Hoda Badr; Vishal Gupta; Andrew Sikora; Marshall Posner
Journal:  Oral Oncol       Date:  2014-08-03       Impact factor: 5.337

9.  Development of a new lingual range-of-motion assessment scale: normative data in surgically treated oral cancer patients.

Authors:  C L Lazarus; H Husaini; A S Jacobson; J K Mojica; D Buchbinder; D Okay; M L Urken
Journal:  Dysphagia       Date:  2014-05-09       Impact factor: 3.438

10.  Case study: application of isometric progressive resistance oropharyngeal therapy using the Madison Oral Strengthening Therapeutic device.

Authors:  Junerose Juan; Jacqueline Hind; Corinne Jones; Timothy McCulloch; Ron Gangnon; JoAnne Robbins
Journal:  Top Stroke Rehabil       Date:  2013 Sep-Oct       Impact factor: 2.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.